Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension

It has been hypothesized that simvastatin could be used to treat pulmonary arterial hypertension (PAH). This study is intended to formulate a simvastatin nanoparticle dry powder inhalation (DPI) formulation. Simvastatin nanoparticles were prepared via an emulsification and homogenization-extrusion m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zendehdel Baher, Shalaleh, Yaqoubi, Shadi, Asare-Addo, Kofi, Hamishehkar, Hamed, Nokhodchi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145523/
https://www.ncbi.nlm.nih.gov/pubmed/35631481
http://dx.doi.org/10.3390/pharmaceutics14050895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145523/
https://www.ncbi.nlm.nih.gov/pubmed/35631481
http://dx.doi.org/10.3390/pharmaceutics14050895

Ejemplares similares